- ELITechGroup launches their first kit of the Gastrointestinal assay panel targeting bacterial pathogens.
- ELITechGroup is planning to launch three additional kits covering the full range of gastrointestinal infections within the next quarter.
In a significant move towards advancing global diagnostic capabilities, ELITechGroup proudly announces the introduction of the GI Bacterial PLUS ELITe MGB® Kit, a robust addition to its diagnostic portfolio. Tailored specifically for diagnosing gastrointestinal bacterial infections, the in vitro assay exclusively targets major bacterial pathogens including Campylobacter spp., Clostridium difficile, Salmonella spp., Shigella spp., and Yersinia enterocolitica. These pathogens are widely acknowledged as significant contributors to global food and waterborne, as well as hospital-acquired, gastrointestinal infections.
The entire process underlying the GI Bacterial PLUS ELITe MGB® Kit, from extraction to result interpretation, has achieved CE-IVDR certification, underscoring ELITechGroup’s unwavering commitment to the highest standards of quality. Fully validated with ELITe InGenius and ELITe BeGenius sample-to-result instruments, the kit is designed to deliver precision diagnostics of human stool specimens.
Aligning with the company’s dedication to precision molecular diagnostics, ELITechGroup is set to launch three more in vitro diagnostic kits for Gastrointestinal Infections, covering parasitic and viral pathogens- GI Parasitic PLUS ELITe MGB® Kit, GI Viral PLUS ELITe MGB® Kit, and GI Norovirus PLUS ELITe MGB® Kit.
These new launches aim to provide a comprehensive solution for the management of life-threatening gastrointestinal infections marking a pivotal milestone in ELITechGroup’s mission to provide state-of-the-art diagnostic solutions.
About ELITechGroup
ELITechGroup is an integrated in-vitro diagnostics company that serves hospitals and diagnostic laboratories in more than 100 countries. The company develops, manufactures, and markets a wide range of diagnostic products and solutions – instruments, reagents, and software.
ELITech Molecular Diagnostics (MDx), one of the four business units of ELITechGroup, serves the needs of clinical and research laboratories by offering a wide range of molecular diagnostic products, including nearly 60 CE-IVD assays and instruments as well as software applications.
